United States

Vita 34 AG (V3VGn.DE)

V3VGn.DE on Xetra

11:33am EDT
Change (% chg)

€0.16 (+2.75%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Vita 34 FY revenues up 15 pct at 16.3 million euros
Monday, 13 Mar 2017 02:00am EDT 

Vita 34 AG : FY sales revenues increased by 15.0 percent to 16.3 million euros following 14.2 million euros previous year . FY EBITDA in reporting period was 2.3 million euros (fiscal year 2015 adjusted for one-time acquisition-related effects: 0.8 million euros) . FY EBIT of 0.8 million euros was also clearly higher than prior year's value, which adjusted for one-time acquisition-related effects was -1.5 million euros . Proposes to pay a dividend in amount of 0.16 euros per share for 2016 . For 2017 expects an increase in revenue of 7 to 10 percent and a continuing stable and high EBITDA margin of some 15 percent thanks to expansion of sales regions and even greater penetration of existing markets .Total operating revenues in current year are expended to be at prior year's level, corrected for special effects, which is equivalent to an increase of c. 3 percent.  Full Article

Vita 34 9-mth revenues up 16.9 pct to 12.0 million euros
Monday, 21 Nov 2016 01:30am EST 

Vita 34 AG : Was able to increase revenues in first nine months of 2016 by 16.9 percent to 12.0 million euros ($12.72 million) (first 9 months 2015: 10.3 million euros) . 9-month total operating revenue also increased by 16.9 percent to 13.3 million euros (first nine months 2015: 11.4 million euros) . 9-month EBITDA totaled 1.6 million euros and was, therefore, nearly at prior year's level despite integration costs for newly acquired companies (first nine months 2015: 1.7 million euros) . EBIDTA rose in annual comparison after rapid integration successes of subsidiaries . Expects an EBITDA margin towards upper end of forecast range of 8-12 percent for full year .A solid increase is also expected in revenues and total operating profit for full year.  Full Article

Vita 34 H1 revenue up 25 pct at 8.0 million euros
Tuesday, 23 Aug 2016 01:00am EDT 

Vita 34 AG : Increases revenue by 25 percent in first half-year 2016 . H1 revenue increased by 25 percent from some 6.4 million euros to 8.0 million euros ($9.07 million) . H1 operating revenue rose by 22 percent to 8.7 million euros (first half-year 2015: 7.1 million euros) .H1 EBIT decreased to 0.3 million euros (first half-year 2015: 0.6 million euros).  Full Article

Vita 34 Q1 sales revenues up 24.2 pct to EUR 3.8 million
Wednesday, 25 May 2016 04:10am EDT 

Vita 34 AG : Vita 34 starts successful into 2016; total operating revenue up by 16.3 percent . Q1 sales revenues increased by 24.2 percent to a total of 3.8 million euros ($4.24 million) (Q1 2015: 3.1 million euros) . In Q1 increased total operating income as compared with last year by 16.3 percent to 4.0 million euros (Q1 2015: 3.4 million euros) .Q1 EBITDA was 0.3 million euros (Q1 2015: 0.6 million euros).  Full Article

Vita 34 appoints Wolfgang Knirsch as Director of Sales and Marketing
Tuesday, 17 May 2016 12:08pm EDT 

Vita 34 AG : Management board at Vita34 expanded with director of sales and marketing .Appointed Wolfgang Knirsch as director of sales and marketing effective June 1.  Full Article

VITA 34 proposes dividend of 0.16 euros per share
Monday, 21 Mar 2016 01:58pm EDT 

VITA 34 AG:To propose an increase of the dividend payment by 6.7 percent to 0.16 euros per share.  Full Article

VITA 34 new CFO Falk Neukirch as of Oct. 1
Monday, 28 Sep 2015 01:04am EDT 

VITA 34 AG:As of Oct. 1 new CFO at Vita 34 AG will be Falk Neukirch.Falk Neukirch will be taking over helm from Joerg Ulbrich, who was a member of management board for 7 years.  Full Article

VITA 34 takes over Danish StemCare Group
Tuesday, 8 Sep 2015 04:01am EDT 

VITA 34 AG:Takes over Danish StemCare Group.Final takeover will take place after fulfillment of all suspensive conditions, among them is transfer of official permits.Management expects these conditions to be fulfilled in Q1 of 2016.  Full Article

VITA 34 AG acquires 30 pct of Bio Save shares
Wednesday, 1 Jul 2015 09:17am EDT 

VITA 34 AG:Acquired 30 pct of company shares of cooperation partner Bio Save (Serbia).Purchase is fully financed out of liquid funds from Vita 34.  Full Article

More From Around the Web

BRIEF-Vita 34 FY revenues up 15 pct at 16.3 million euros

* FY sales revenues increased by 15.0 percent to 16.3 million euros following 14.2 million euros previous year